A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients

• Status: Completed
• Trial end date: 2017-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to understand the feasibility of a text messaging intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve smoking cessation among opiate and/or alcohol dependent participants discharged from an inpatient detoxification unit and enrolled in an office-based buprenorphine program patients (OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of informational pamphlets and information for a 1800 quit line; and a prescription for a nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which is offered routinely to all inpatients at Bellevue at the time of discharge) versus the SmokeFreeTXT intervention plus prescriptions for NRT.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Buprenorphine; Nicotine

Criteria

Inclusion Criteria:

• self-described every or some day smoker

• diagnosed with opiate dependence and/or alcohol dependence (DSM-IV) per Physician medical records (MISYS)

• Fluency in English and able to provide a written informed consent

• Currently owning a mobile phone with a working phone number

• Expected to reside in the New York City area for the next 12 months

• Understands and able to respond to the intervention text message

Exclusion Criteria:

• inability to read or understand English

• currently using nicotine replacement therapies (patch, gum, e-cigarettes), pharmacotherapy for smoking cessation such as bupropion (zyban, wellbutrin), varenicline (Chantix).

• suicidal or homicidal ideations

• any ongoing psychotic disorder, life-threatening medical or psychiatric condition

• leaves the inpatient detoxification unit prior to completing study enrollment

• is pregnant, nursing or planning to conceive within the duration of the study period